# Scynexis Inc: filings

SCYX · Nasdaq · CIK 1178253 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/scyx.md) · [Financials](/companies/scyx/financials.md) · [Filings](/companies/scyx/filings.md) · [Insiders](/companies/scyx/insiders.md)

## Reports and events: 174 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 270, 8-K 100, 10-Q 38, 3 35, SC 13G/A 35, S-8 20, 424B5 19, CORRESP 17, SC 13G 17, 144 16, DEF 14A 15, UPLOAD 14, 10-K 12, EFFECT 12, DEFA14A 11, CT ORDER 10, S-3 10, 424B3 8, SCHEDULE 13G/A 8, PRE 14A 7, 4/A 6, ARS 4, S-1/A 4, SCHEDULE 13G 4, 10-K/A 2, 3/A 2, 424B4 2, D/A 2, FWP 2, S-1 2, 10-Q/A 1, 8-A12B 1, CERTNAS 1, D 1, DRS 1, DRS/A 1, NT 10-Q 1, S-1MEF 1, S-3/A 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-09-28 | 16:01 ET | [8-K](/filings/0001178253-26-000037.md) | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001178253-26-000037 |
| 2026-09-22 | 08:05 ET | [8-K](/filings/0001178253-26-000035.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001178253-26-000035 |
| 2026-09-10 | 08:05 ET | [8-K](/filings/0001178253-26-000031.md) | 5.02 Departure or appointment of officers or directors; 8.01 Other events | 0001178253-26-000031 |
| 2026-08-10 | 16:01 ET | [10-Q](/filings/0001178253-26-000027.md) | Quarterly report, period 2026-06-30 | 0001178253-26-000027 |
| 2026-06-26 | 16:01 ET | [8-K](/filings/0001178253-26-000021.md) | 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 8.01 Other events; 9.01 Financial statements and exhibits | 0001178253-26-000021 |
| 2026-05-29 | 16:01 ET | [8-K](/filings/0001178253-26-000017.md) | 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001178253-26-000017 |
| 2026-05-22 | 16:20 ET | [8-K](/filings/0001178253-26-000014.md) | 5.07 Shareholder vote results; 8.01 Other events | 0001178253-26-000014 |
| 2026-05-11 | 16:01 ET | [10-Q](/filings/0001178253-26-000011.md) | Quarterly report, period 2026-03-31 | 0001178253-26-000011 |
| 2026-04-30 | 16:29 ET | [DEF 14A](/filings/0001140361-26-018207.md) | Proxy statement, period 2026-06-25 | 0001140361-26-018207 |
| 2026-04-27 | 16:18 ET | [DEF 14A](/filings/0001140361-26-017112.md) | Proxy statement, period 2026-05-19 | 0001140361-26-017112 |
| 2026-04-20 | 16:01 ET | [8-K](/filings/0001178253-26-000009.md) | 5.02 Departure or appointment of officers or directors | 0001178253-26-000009 |
| 2026-03-31 | 16:03 ET | [8-K](/filings/0001193125-26-134476.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-134476 |
| 2026-03-31 | 07:05 ET | [8-K](/filings/0001193125-26-133259.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-133259 |
| 2026-03-31 | 07:00 ET | [8-K](/filings/0001193125-26-133250.md) | 1.01 Entry into a material agreement; 2.01 Completion of an acquisition or disposition; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-133250 |
| 2026-03-04 | 16:01 ET | [10-K](/filings/0001178253-26-000007.md) | Annual report, period 2025-12-31 | 0001178253-26-000007 |
| 2025-11-05 | 16:01 ET | [10-Q](/filings/0001178253-25-000010.md) | Quarterly report, period 2025-09-30 | 0001178253-25-000010 |
| 2025-10-15 | 08:00 ET | [8-K](/filings/0001178253-25-000006.md) | 1.01 Entry into a material agreement | 0001178253-25-000006 |
| 2025-08-13 | 16:01 ET | [10-Q](/filings/0000950170-25-107985.md) | Quarterly report, period 2025-06-30 | 0000950170-25-107985 |
| 2025-07-01 | 16:01 ET | [8-K](/filings/0000950170-25-092176.md) | 5.07 Shareholder vote results | 0000950170-25-092176 |
| 2025-06-26 | 16:01 ET | [8-K](/filings/0000950170-25-090374.md) | 3.01 Delisting notice | 0000950170-25-090374 |
| 2025-05-15 | 16:01 ET | [10-Q](/filings/0000950170-25-072548.md) | Quarterly report, period 2025-03-31 | 0000950170-25-072548 |
| 2025-04-30 | 16:01 ET | [DEF 14A](/filings/0001140361-25-016641.md) | Proxy statement, period 2025-06-25 | 0001140361-25-016641 |
| 2025-03-12 | 16:55 ET | [10-K](/filings/0000950170-25-038044.md) | Annual report, period 2024-12-31 | 0000950170-25-038044 |
| 2024-11-06 | 16:10 ET | [8-K](/filings/0000950170-24-122291.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-24-122291 |
| 2024-11-06 | 16:01 ET | [10-Q](/filings/0000950170-24-122241.md) | Quarterly report, period 2024-09-30 | 0000950170-24-122241 |
| 2024-09-10 | 08:01 ET | [8-K](/filings/0000950170-24-104918.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-24-104918 |
| 2024-08-08 | 16:01 ET | [10-Q](/filings/0000950170-24-093856.md) | Quarterly report, period 2024-06-30 | 0000950170-24-093856 |
| 2024-06-20 | 08:07 ET | [8-K](/filings/0000950170-24-075321.md) | 5.07 Shareholder vote results | 0000950170-24-075321 |
| 2024-05-08 | 16:01 ET | [10-Q](/filings/0000950170-24-055590.md) | Quarterly report, period 2024-03-31 | 0000950170-24-055590 |
| 2024-04-25 | 16:33 ET | [DEF 14A](/filings/0001140361-24-022086.md) | Proxy statement, period 2024-06-19 | 0001140361-24-022086 |
| 2024-03-28 | 16:11 ET | [10-K](/filings/0000950170-24-038046.md) | Annual report, period 2023-12-31 | 0000950170-24-038046 |
| 2024-03-28 | 16:04 ET | [8-K](/filings/0000950170-24-038015.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-038015 |
| 2024-01-05 | 09:53 ET | [8-K](/filings/0000950170-24-002308.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-24-002308 |
| 2024-01-02 | 16:01 ET | [8-K](/filings/0000950170-24-000238.md) | 1.01 Entry into a material agreement | 0000950170-24-000238 |
| 2023-11-13 | 16:01 ET | [10-Q](/filings/0000950170-23-062894.md) | Quarterly report, period 2023-09-30 | 0000950170-23-062894 |
| 2023-10-02 | 09:15 ET | [8-K](/filings/0000950170-23-050940.md) | 8.01 Other events | 0000950170-23-050940 |
| 2023-09-25 | 08:32 ET | [8-K](/filings/0000950170-23-049544.md) | 8.01 Other events | 0000950170-23-049544 |
| 2023-08-14 | 16:01 ET | [10-Q](/filings/0000950170-23-042362.md) | Quarterly report, period 2023-06-30 | 0000950170-23-042362 |
| 2023-06-23 | 16:01 ET | [8-K](/filings/0000950170-23-029599.md) | 1.02 Termination of a material agreement; 8.01 Other events | 0000950170-23-029599 |
| 2023-06-16 | 16:01 ET | [8-K](/filings/0000950170-23-028589.md) | 5.07 Shareholder vote results | 0000950170-23-028589 |
| 2023-05-10 | 16:02 ET | [10-Q](/filings/0000950170-23-020486.md) | Quarterly report, period 2023-03-31 | 0000950170-23-020486 |
| 2023-05-01 | 16:05 ET | [DEF 14A](/filings/0001140361-23-022024.md) | Proxy statement, period 2023-06-14 | 0001140361-23-022024 |
| 2023-03-31 | 07:16 ET | [10-K](/filings/0000950170-23-011138.md) | Annual report, period 2022-12-31 | 0000950170-23-011138 |
| 2023-03-30 | 07:08 ET | [8-K](/filings/0000950170-23-010748.md) | 1.01 Entry into a material agreement | 0000950170-23-010748 |
| 2022-11-09 | 16:03 ET | [10-Q](/filings/0000950170-22-023822.md) | Quarterly report, period 2022-09-30 | 0000950170-22-023822 |
| 2022-11-09 | 07:16 ET | [8-K](/filings/0000950170-22-023510.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-22-023510 |
| 2022-10-20 | 17:21 ET | [8-K](/filings/0001564590-22-034777.md) | 1.02 Termination of a material agreement; 5.02 Departure or appointment of officers or directors | 0001564590-22-034777 |
| 2022-09-30 | 16:01 ET | [8-K](/filings/0001564590-22-032963.md) | 5.07 Shareholder vote results | 0001564590-22-032963 |
| 2022-08-19 | 16:00 ET | [DEF 14A](/filings/0001140361-22-030371.md) | Proxy statement, period 2022-09-28 | 0001140361-22-030371 |
| 2022-08-15 | 16:03 ET | [10-Q](/filings/0001564590-22-029486.md) | Quarterly report, period 2022-06-30 | 0001564590-22-029486 |

Page 1 of 4. [Older](/companies/scyx/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:06 ET. No prices; not investment advice.